Acumen Pharmaceuticals, Inc. (ABOS)
NASDAQ: ABOS · Real-Time Price · USD
1.120
-0.090 (-7.44%)
At close: Jun 27, 2025, 4:00 PM
1.110
-0.010 (-0.89%)
After-hours: Jun 27, 2025, 6:06 PM EDT
Acumen Pharmaceuticals Market Cap
Acumen Pharmaceuticals has a market cap or net worth of $67.84 million as of June 27, 2025. Its market cap has decreased by -56.90% in one year.
Market Cap
67.84M
Enterprise Value
-94.87M
1-Year Change
-56.90%
Ranking
Category
Stock Price
$1.12
Market Cap Chart
Since the IPO on July 1, 2021, Acumen Pharmaceuticals's market cap has decreased from $618.43M to $67.84M, a decrease of -89.03%. That is a compound annual growth rate of -42.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2025 | 73.29M | -29.07% |
| Dec 31, 2024 | 103.34M | -53.53% |
| Dec 29, 2023 | 222.38M | 0.62% |
| Dec 30, 2022 | 221.00M | -19.22% |
| Dec 31, 2021 | 273.58M | -55.76% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 711.28B |
| Johnson & Johnson | 366.40B |
| AbbVie | 327.47B |
| Novo Nordisk | 301.06B |
| UnitedHealth Group | 273.97B |
| Abbott Laboratories | 239.05B |
| Novartis AG | 231.01B |
| AstraZeneca | 216.45B |